Physician profile
James A Murphy
NPI 1801874276
$1,466.51
in general payments reported to CMS, 2019-2025
20 companies · $87.20 in 2025
The $87.20 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $135 · 2021: $313 · 2022: $335 · 2023: $210 · 2024: $135 · 2025: $87.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $432.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $432.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $383.17 | 2019-2025 | |
| Organon LLC | $143.63 | 2021-2025 | Nexplanon |
| Pfizer INC. | $136.70 | 2019-2023 | |
| Astellas Pharma US INC | $113.50 | 2021-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $92.21 | 2021-2023 | Slynd |
| Mayne Pharma Commercial LLC | $88.22 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $86.40 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $75.07 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.98 | 2019-2020 | |
| Hologic Sales and Service, LLC | $58.84 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Avanos Medical | $34.33 | 2019-2021 | |
| Shield Therapeutics INC | $31.92 | 2023-2024 | Accrufer |
| Duchesnay USA Incorporated | $26.75 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $22.48 | 2022 | |
| Aspira Women'S Health INC | $22.47 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $21.61 | 2022 | |
| Lupin INC. | $18.68 | 2019 | |
| Lsi Solutions INC | $17.00 | 2024 | Fornisee |
| Therapeuticsmd, INC. | $13.51 | 2022 | |
| Amag Pharmaceuticals, INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.